Pharmagest/EQUASENS – RESULTS OF THE VOTE ON THE RESOLUTIONS PRESENTED TO THE EXTRAORDINARY GENERAL MEETING OF MAY 6, 2022 – 05/10/2022 at 07:02


The Extraordinary General Meeting met on Friday May 6, 2022 at 5 p.m. at the Company’s registered office and approved the resolutions proposed by the Board of Directors:

 FIRST RESOLUTION
Modification of the company name and correlative modification of article 3 of the articles of association Resolution adopted by:
– 13,053,001 votes for
– 32,074 votes against
– 0 abstentions

 SECOND RESOLUTION
Powers to complete the formalities Resolution adopted by:
– 13,053,001 votes for
– 32,074 votes against
– 0 abstentions

The Extraordinary General Meeting of shareholders held on May 6 at the company’s registered office adopted the resolution relating to the change of name to EQUASENS.

About the Equasens Group:
With more than 1,200 employees “Citizens of health and well-being”, the Equasens Group is today a structuring player in the world of Health in Europe which addresses its software solutions to all health professionals (pharmacists , private doctors, hospitals, HAD structures, retirement homes, nursing homes) in the city as well as in the hospital.
Present in France, Italy, Belgium, Luxembourg and Great Britain, the Equasens Group is now developing the first health platform, a unique ecosystem in France and Europe, which puts the best of technology at the service of the ‘human.

Listed on Euronext Paris™ – Compartment A
ISIN: FR0012882389



Source link -86